C

CareDx
D

CDNA

21.350
USD
0.69
(3.34%)
Market Open
Volume
13,180
EPS
-1
Div Yield
-
P/E
-8
Market Cap
1,143,474,130
Related Instruments
    A
    ACU
    -0.440
    (-1.17%)
    37.300 USD
    B
    BCRX
    0.06000
    (0.79%)
    7.63000 USD
    C
    CGA
    0.12000
    (6.78%)
    1.89000 USD
    C
    CMP
    -0.110
    (-1.03%)
    10.520 USD
    C
    CRIS
    0.19000
    (6.13%)
    3.29000 USD
    C
    CTIC
    0.11000
    (2.54%)
    4.44000 USD
    NTR
    NTR
    -0.350
    (-0.78%)
    44.240 USD
    More
News

Title: CareDx

Sector: Healthcare
Industry: Diagnostics & Research
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.